Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of neural transmission. Supplementum

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-3-7091-6262-0_15PMID 11771743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.

  2000cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• Oxidative stress and neural dysfunction in Down syndrome.

  1999cited by this paper
• Oxidative Alterations in Alzheimer's Disease

  1999cited by this paper
• Reduced aldehyde dehydrogenase levels in the brain of patients with Down syndrome.

  1999cited by this paper
• Two‐dimensional map of human brain proteins

  1999cited by this paper
• Biomarkers of oxidative stress are significantly elevated in Down syndrome.

  1998cited by this paper
• Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

  1998cited by this paper
• Carbonyl‐Trapping Therapeutic Strategies

  1998cited by this paper
• Molecular genetic aspects of alcohol metabolism and alcoholism

  1997cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997cited by this paper
• Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery.

  1997cited by this paper
• An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease

  1997cited by this paper
• Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two‐dimensional gel electrophoresis

  1997cited by this paper
• Molecular Genetic Aspects of Alcohol Metabolism and Alcoholism

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Biochemistry of redox reactions

  1995cited by this paper
• Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease

  1995cited by this paper
• A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

  1994cited by this paper
• Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease.

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative.

  1994cited by this paper
• Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells.

  1993cited by this paper
• Immunohistochemical localization of carbonyl reductase in human tissues.

  1992cited by this paper
• Induction of a human carbonyl reductase gene located on chromosome 21.

  1990cited by this paper
• Human liver alcohol dehydrogenase isozymes: reduction of aldehydes and ketones.

  1984cited by this paper
• Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase.

  1981cited by this paper
• Purification and Properties of an NADPH-dependent Carbonyl Reductase from Human Brain

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Detoxification and Age-Related Neurodegenerative Disease: Correlation and Therapeutic Potential.

  2025cites this paper
• Protein Oxidation in Aging and Alzheimer’s Disease Brain

  2024cites this paper
• LC-Orbitrap HRMS-Based Proteomics Reveals Novel Mitochondrial Dynamics Regulatory Proteins Associated with RasV12-Induced Glioblastoma (GBM) of Drosophila.

  2024cites this paper
• Unraveling the Dynamics of Host–Microbiota Indole Metabolism: An Investigation of Indole, Indolin-2-one, Isatin, and 3-Hydroxyindolin-2-one

  2024cites this paper
• Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

  2024cites this paper
• Oxidative stress and mTOR in Down syndrome brain: Link to Alzheimer's dysmetabolism, neuropathology, and possible therapies

  2022cites this paper
• Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules

  2021cites this paper
• RZiMM-scRNA: A regularized zero-inflated mixture model framework for single-cell RNA-seq data

  2021cites this paper
• Xenobiotic Transport and Metabolism in the Human Brain.

  2021cites this paper
• Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD.

  2020cites this paper
• Plasma metabolome and cognitive skills in Down syndrome

  2020cites this paper
• Prenatal Hypoxia and Placental Oxidative Stress: Insights from Animal Models to Clinical Evidences

  2020cites this paper
• Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials

  2020cites this paper
• A Comprehensive Review on Source, Types, Effects, Nanotechnology, Detection, and Therapeutic Management of Reactive Carbonyl Species Associated with Various Chronic Diseases

  2020cites this paper
• The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia

  2020cites this paper
• Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

  2019cites this paper
• Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism

  2018cites this paper
• The Role of Oxidative Stress in the Pathomechanism of Congenital Malformations

  2018cites this paper
• Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.

  2018cites this paper
• The role of carbonyl reductase 1 in drug discovery and development

  2017cites this paper
• HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.

  2017cites this paper
• Mental Retardation and Human Chromosome 21 Gene Overdosage : From Functional Genomics and Molecular Mechanisms Towards Prevention and Treatment of the Neuropathogenesis of Down Syndrome

  2017cites this paper
• Detoxification of Carbonyl Compounds by Carbonyl Reductase in Neurodegeneration.

  2016cites this paper
• The Benefits of Natural Products for Neurodegenerative Diseases

  2016cites this paper
• Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer’s Disease

  2015cites this paper
• Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.

  2015cites this paper
• In vitro studies using curcumin and curcumin analogues as candidate mitochondria-targeting anticancer agents affecting colon cancer cells

  2014cites this paper
• Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: Insights from proteomics

  2014cites this paper
• Oxidative stress in Down Syndrome

  2014cites this paper
• Perinatal and Prenatal Disorders

  2014cites this paper
• Down Syndrome as a Special Case of Oxidatively Induced Developmental Dysregulation

  2014cites this paper
• Brain Oxidative Stress in the Pathogenesis and Progression of Alzheimer’s Disease

  2013cites this paper
• Viruses and neurodegeneration

  2013cites this paper
• Biomarkers of Oxidative Stress in Neurodegenerative Diseases

  2013cites this paper
• 14 BIOMARKERS OF OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES

  2013cites this paper
• The investigation of oxidative damage to nucleic acids during ageing and motor neuron disease

  2013cites this paper
• Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications

  2012cites this paper
• Oxidative stress and mitochondrial dysfunction in Down syndrome.

  2012cites this paper
• Proteomic Analysis of Protease Resistant Proteins in the Diabetic Rat Kidney

  2012cites this paper
• 4-Hydroxy-2-Nonenal, a Reactive Product of Lipid Peroxidation, and Neurodegenerative Diseases: A Toxic Combination Illuminated by Redox Proteomics Studies

  2012cites this paper
• Mitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10) ?

  2011cites this paper
• Mental Retardation and Human Chromosome 21 Gene Overdosage: From Functional Genomics and Molecular Mechanisms Towards Prevention and Treatment of the Neuropathogenesis of Down Syndrome

  2011cites this paper
• Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

  2011cites this paper
• Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.

  2011cites this paper
• Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia

  2011cites this paper
• Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid

  2011cites this paper
• Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome.

  2011cites this paper
• Lipid peroxidation and neurodegenerative disease.

  2011cites this paper
• The neuroproteomics of schizophrenia.

  2011cites this paper
• Oxidative Stress and Oxidative Damage in Carcinogenesis

  2010cites this paper
• Human carbonyl reductases.

  2010influential citation
• Increased Mitochondrial Aldehydedehydrogenase in the putamen of individuals with Alzheimer's disease

  2010cites this paper
• Expression of the Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 in Hearts from Donors with Down Syndrome

  2010cites this paper
• An update on clinical proteomics in Alzheimer’s research

  2010cites this paper
• Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.

  2010cites this paper
• First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia

  2010cites this paper
• Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

  2008cites this paper
• Interaction Between High‐Fat Diet and Alcohol Dehydrogenase on Ethanol‐Elicited Cardiac Depression in Murine Myocytes

  2007cites this paper
• Proteomics Analysis of the Alzheimer's Disease Hippocampal Proteome

  2007cites this paper
• Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease

  2007cites this paper
• Proteomics of Alzheimer's disease: Unveiling protein dysregulation in complex neuronal systems

  2007cites this paper
• High‐coverage quantitative proteomics using amine‐specific isotopic labeling

  2006cites this paper
• Genetics, transcriptomics, and proteomics of Alzheimer's disease.

  2006cites this paper
• Profiling human brain proteome by multi‐dimensional separations coupled with MS

  2006cites this paper
• [Oxidative stress and Alzheimer's disease].

  2006cites this paper
• Multiple evidence for an early age pro-oxidant state in Down Syndrome patients

  2006cites this paper
• Oxidative stress in Alzheimer's disease.

  2006cites this paper
• Neuroprotective role for carbonyl reductase?

  2006cites this paper
• Markers of oxidative stress in children with Down syndrome

  2006cites this paper
• Proteomics‐driven progress in neurodegeneration research

  2006cites this paper
• Cardiac overexpression of alcohol dehydrogenase (ADH) alleviates aging‐associated cardiomyocyte contractile dysfunction: role of intracellular Ca2+ cycling proteins

  2006cites this paper
• Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation

  2005cites this paper
• The Application of Proteomics in Neurology

  2005cites this paper
• Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases?

  2005cites this paper
• Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function

  2005cites this paper
• Molecular characterization of rat gastric mucosal response to potent acid inhibition.

  2005cites this paper
• Proteomic analysis of inflammatory protein expression patterns in cell culture and transgenic animal models for Alzheimer ’ s disease

  2005cites this paper
• Cytoprotection against oxidative stress‐induced damage of astrocytes by extracellular ATP via P2Y1 receptors

  2005cites this paper
• Investigation of mRNA oxidation in Alzheimer's disease.

  2005cites this paper
• Direct Evaluation of Alzheimer’s Disease-Specific Oxidative Stress with Multiphoton Microscopy

  2005cites this paper
• Risk Factors for Alzheimer's Disease in Down Syndrome

  2004cites this paper
• Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome.

  2004cites this paper
• Proteomic approaches in brain research and neuropharmacology.

  2004cites this paper
• Application of proteomics technologies in the investigation of the brain.

  2004cites this paper
• The Drosophila carbonyl reductase sniffer prevents oxidative stress-induced neurodegeneration.

  2004cites this paper
• Acetaldehyde: déjà vu du jour.

  2004cites this paper
• Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration.

  2004cites this paper
• Proteomic analysis of inflammatory protein expression patterns in cell culture and transgenic animal models for Alzheimer's disease

  2004cites this paper
• Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

  2003cites this paper
• The Identification and Characterization of Oxidized RNAs in Alzheimer's Disease

  2003cites this paper
• Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells.

  2003cites this paper
• Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part I)

  2003cites this paper
• Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part II)

  2003cites this paper
• Carbonyl toxicology and Alzheimer's disease.

  2002cites this paper
• Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia Like Dementia

  year unknowncites this paper
• Estrés oxidativo y enfermedad de Alzheimer

  year unknowncites this paper